Sussex Formulary
  • About The Formulary
  • Using The Formulary
  • Therapeutic Sections
    • 1 Gastro-intestinal system
    • 2 Cardiovascular system
    • 3 Respiratory system
    • 4 Nervous system
    • 5 Infection
    • 6 Endocrine system
    • 7 Genito-urinary system
    • 8 Immune system & malignant disease
    • 9 Blood and nutrition
    • 10 Musculoskeletal system
    • 11 Eye
    • 12 Ear, nose and oropharynx
    • 13 Skin
    • 14 Vaccines
    • 15 Anaesthesia
    • 16 Emergency treatment of poisoning
    • 17 Nausea and Vomiting in Pregnancy and Hyperemesis Gravidarum
    • Appendix 1 - Borderline substances
    • Appendix 2 - Wound management products and elasticated garments
    • Appendix 3 - Continence
    • Appendix 4 - Palliative care
  • Drug Index
  • Antimicrobial Guidance
  • Shared Care Protocols
    • Sussex-wide protocols
    • Brighton & Hove protocols
    • East Sussex protocols
    • West Sussex protocols
  • Position statements
  • Not Recommended Items
  • APC Summaries
    • 2025
    • 2024
    • 2023
  • APC Minutes
    • 2021
    • 2022
    • 2023
    • 2024
    • 2025
    • 2026
  • Discontinuations
  • Contact us
  • About The Formulary
  • Using The Formulary
  • Therapeutic Sections
    • 1 Gastro-intestinal system
    • 2 Cardiovascular system
      • 2.1 Arrhythmias
      • 2.2 Bleeding disorders
      • 2.3 Blood clots
      • 2.4 Blood pressure conditions
      • 2.5 Cardiovascular risk assessment and prevention
      • 2.6 Heart failure
      • 2.7 Hyperlipidaemia
      • 2.8 Myocardial ischaemia
        • 2.8.1 Acute coronary syndromes
        • 2.8.1a Cardiac arrest
      • 2.9 Vascular disease
      • 2.10 Other Cardiovascular system items
    • 3 Respiratory system
    • 4 Nervous system
    • 5 Infection
    • 6 Endocrine system
    • 7 Genito-urinary system
    • 8 Immune system & malignant disease
    • 9 Blood and nutrition
    • 10 Musculoskeletal system
    • 11 Eye
    • 12 Ear, nose and oropharynx
    • 13 Skin
    • 14 Vaccines
    • 15 Anaesthesia
    • 16 Emergency treatment of poisoning
    • 17 Nausea and Vomiting in Pregnancy and Hyperemesis Gravidarum
    • Appendix 1 - Borderline substances
    • Appendix 2 - Wound management products and elasticated garments
    • Appendix 3 - Continence
    • Appendix 4 - Palliative care
  • Drug Index
  • Antimicrobial Guidance
  • Shared Care Protocols
  • Position statements
  • Not Recommended Items
  • APC Summaries
  • APC Minutes
  • Discontinuations
  • Contact us
  • Search

Drug Status Key

  • Non-Specialist Drugs
  • Specialist recommendation (or initiation where noted)
  • Specialist Initiation WITH Shared Care Guidelines
  • Specialist ONLY Drugs
  • Mixed Status - See individual drug entries for more details

Preferences

  • First Line
  • Second Line
  • Third Line
  • No Preference

Alteplase

{ Value = NICE, Index = 0 } { Value = EMC, Index = 3 }

Alteplase 25micrograms/0.1ml solution for injection vials

Pack
1 vial

Alteplase 4mg/4ml solution for injection vials

Pack
1 vial
10 vial

Alteplase 2mg powder for solution for injection vials

Pack
5 vial

Alteplase 2mg powder and solvent for solution for injection vials

Pack
5 vial

Alteplase 10mg powder and solvent for solution for injection vials

Pack
1 vial

Alteplase 20mg powder and solvent for solution for injection vials

Pack
1 vial

Dobutamine

{ Value = NICE, Index = 0 } { Value = EMC, Index = 3 }

Dobutamine 250mg/5ml solution for infusion ampoules

Pack
5 ampoule

Dobutamine 250mg/20ml solution for infusion ampoules

Pack
5 ampoule
10 ampoule

Dobutamine 250mg/20ml solution for infusion vials

Pack
1 vial

Dobutamine 250mg/50ml solution for infusion vials

Pack
1 vial

Dobutamine 100mg/100ml infusion bags

Pack
1 bag
10 bag

Dobutamine 500mg/100ml infusion bags

Pack
1 bag
10 bag

Glyceryl trinitrate

{ Value = NICE, Index = 0 } { Value = EMC, Index = 3 }

S/L tablets once opened should be discarded after 8 weeks.

Glyceryl trinitrate 300microgram sublingual tablets

Pack
100 tablet

Glyceryl trinitrate 500microgram sublingual tablets

Pack
100 tablet

Glyceryl trinitrate 600microgram sublingual tablets

Pack
100 tablet

Glyceryl trinitrate 400micrograms/dose pump sublingual spray

Pack
180 dose
200 dose
75 dose

Glyceryl trinitrate 400micrograms/dose aerosol sublingual spray

Pack
180 dose
200 dose

Glyceryl trinitrate 5mg/24hours transdermal patches

Pack
28 patch
30 patch
15 patch

Glyceryl trinitrate 10mg/24hours transdermal patches

Pack
30 patch
28 patch
15 patch

Glyceryl trinitrate 15mg/24hours transdermal patches

Pack
30 patch
28 patch

Glyceryl trinitrate 50mg/50ml solution for infusion vials

Pack
1 vial
25 vial

Glyceryl trinitrate 5mg/5ml solution for infusion ampoules

Pack
10 ampoule

Glyceryl trinitrate 10mg/10ml solution for infusion ampoules

Pack
10 ampoule

Glyceryl trinitrate 25mg/5ml solution for infusion ampoules

Pack
5 ampoule

Glyceryl trinitrate 50mg/10ml solution for infusion ampoules

Pack
5 ampoule

Isosorbide dinitrate

{ Value = NICE, Index = 0 } { Value = EMC, Index = 3 }

Isosorbide dinitrate 10mg/10ml solution for injection ampoules

Pack
10 ampoule

Isosorbide mononitrate

{ Value = NICE, Index = 0 } { Value = EMC, Index = 3 }

Isosorbide Mononitrate modified release capsules are considered first line.

Isosorbide mononitrate 10mg tablets

Pack
84 tablet
60 tablet
56 tablet
100 tablet

Isosorbide mononitrate 20mg tablets

Pack
56 tablet
60 tablet
100 tablet
84 tablet
50 tablet

Isosorbide mononitrate 30mg tablets

Pack
56 tablet

Isosorbide mononitrate 40mg tablets

Pack
56 tablet
60 tablet
100 tablet
84 tablet

Isosorbide mononitrate 25mg modified-release capsules

Pack
28 capsule

Isosorbide mononitrate 40mg modified-release capsules

Pack
28 capsule

Isosorbide mononitrate 50mg modified-release capsules

Pack
28 capsule
30 capsule

Isosorbide mononitrate 60mg modified-release capsules

Pack
28 capsule

Isosorbide mononitrate 25mg modified-release tablets

Pack
28 tablet

Isosorbide mononitrate 40mg modified-release tablets

Pack
28 tablet
30 tablet

Isosorbide mononitrate 50mg modified-release tablets

Pack
28 tablet

Isosorbide mononitrate 60mg modified-release tablets

Pack
30 tablet
28 tablet
60 tablet

Mavacamten

Black Triangle { Value = NICE, Index = 0 } { Value = EMC, Index = 3 }

Mavacamten 2.5mg capsules

Pack
28 capsule

Mavacamten 5mg capsules

Pack
28 capsule

Prasugrel

Black Triangle { Value = MHRA Warning Exists, Index = 4 } { Value = NICE, Index = 0 } { Value = EMC, Index = 3 }

Prasugrel 5mg tablets

Pack
28 tablet

Prasugrel 10mg tablets

Pack
28 tablet
30 tablet

Streptokinase

{ Value = NICE, Index = 0 } { Value = EMC, Index = 3 }

Streptokinase 250,000unit powder for solution for infusion vials

Pack
1 vial

Streptokinase 750,000unit powder for solution for infusion vials

Pack
1 vial

Streptokinase 1.5million unit powder for solution for infusion vials

Pack
1 vial

Tenecteplase

{ Value = NICE, Index = 0 } { Value = EMC, Index = 3 }

Tenecteplase 8,000unit powder and solvent for solution for injection vials

Pack
1 vial

Tenecteplase 10,000unit powder and solvent for solution for injection vials

Pack
1 vial

Ticagrelor

{ Value = NICE, Index = 0 } { Value = EMC, Index = 3 }

Ticagrelor 60mg tablets

Pack
56 tablet

Ticagrelor 90mg tablets

Pack
56 tablet

Online Formulary by M.O.M. Systems

NICE guidance is available from https://www.nice.org.uk/guidance All rights reserved. Subject to Notice of rights.
NICE guidance is prepared for the National Health Service in England. All NICE guidance is subject to regular review and may be updated or withdrawn. NICE accepts no responsibility for the use of its content in this product/publication.

© Copyright 2026